Herbert Budka Selected Research

Herbert Budka Research Topics

Disease

36	Prion Diseases (Transmissible Spongiform Encephalopathies) 10/2020 - 01/2002
22	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2020 - 01/2002
16	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 09/2002
14	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2002
12	Multiple System Atrophy 09/2014 - 09/2002
12	Neoplasms (Cancer) 10/2007 - 03/2002
11	Parkinson Disease (Parkinson's Disease) 09/2014 - 03/2002
8	Sporadic Creutzfeldt-Jakob Disease 01/2015 - 01/2004
8	Dementia (Dementias) 09/2014 - 04/2006
7	Infections 01/2017 - 02/2004
7	Acquired CJD 12/2013 - 05/2003
6	Lewy Body Disease (Lewy Body Dementia) 07/2012 - 03/2002
6	Synucleinopathies 07/2012 - 11/2004
6	Glioblastoma (Glioblastoma Multiforme) 04/2007 - 07/2002
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2020 - 09/2002
5	Multiple Sclerosis 03/2016 - 02/2004
4	Scrapie 01/2017 - 09/2005
4	Inclusion Body Myositis 01/2013 - 01/2004
4	Ependymoma 04/2007 - 07/2004
3	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2021 - 09/2009
3	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 02/2009
3	Atrophy 08/2017 - 03/2003
3	Gliosis 09/2014 - 03/2006
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012 - 12/2004
3	Disease Progression 09/2011 - 04/2004
3	Amyloid Plaque 09/2011 - 04/2002
3	Astrocytoma (Pilocytic Astrocytoma) 04/2007 - 11/2003
2	Tauopathies 10/2016 - 08/2011
2	Progressive Multifocal Leukoencephalopathy 10/2013 - 02/2004
2	Dermatomyositis (Dermatopolymyositis) 01/2013 - 07/2008
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2012 - 09/2007
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2012 - 03/2006
2	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 10/2010 - 11/2007
2	Motor Neuron Disease (Primary Lateral Sclerosis) 09/2010 - 09/2002
2	Demyelinating Diseases (Demyelinating Disease) 06/2008 - 09/2003
2	Inflammation (Inflammations) 06/2008 - 09/2007
2	Guillain-Barre Syndrome 06/2008 - 10/2006
2	Neuroblastoma 04/2007 - 07/2003
2	Medulloblastoma 04/2007 - 11/2006
2	Lymphoma (Lymphomas) 04/2007 - 10/2006
2	Oligodendroglioma 04/2007 - 03/2002
2	Brain Ischemia (Cerebral Ischemia) 03/2006 - 12/2002
2	Hypoxia (Hypoxemia) 02/2005 - 04/2003
2	Necrosis 01/2005 - 07/2004
2	Fatal Familial Insomnia 11/2002 - 01/2002
1	COVID-19 01/2023
1	Glioma (Gliomas) 01/2018
1	Parasomnias (Parasomnia) 10/2016
1	Respiratory Sounds (Crackle) 10/2016
1	Sleep Apnea Syndromes (Sleep Apnea) 10/2016
1	Hypertension (High Blood Pressure) 09/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016
1	Cognitive Dysfunction 01/2016
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016
1	Proteostasis Deficiencies 01/2016
1	Central Nervous System Diseases (CNS Diseases) 10/2013

Drug/Important Bio-Agent (IBA)

33	Prion ProteinsIBA 10/2020 - 01/2002
27	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2002
13	PrionsIBA 10/2020 - 01/2004
9	Amyloid (Amyloid Fibrils)IBA 01/2016 - 06/2003
8	14-3-3 Proteins (14-3-3 Protein)IBA 12/2013 - 03/2002
6	alpha-SynucleinIBA 10/2008 - 11/2004
6	ParaffinIBA 11/2006 - 12/2002
5	AntibodiesIBA 10/2016 - 09/2003
5	Codon (Codons)IBA 11/2011 - 11/2002
4	SynucleinsIBA 09/2014 - 01/2008
4	Protein Isoforms (Isoforms)IBA 01/2012 - 09/2002
3	CytokinesIBA 01/2023 - 08/2009
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2010
3	Cathepsin DIBA 03/2013 - 07/2007
3	TubulinIBA 11/2010 - 11/2004
3	Peptide Hydrolases (Proteases)FDA Link 06/2006 - 09/2005
3	Formaldehyde (Formol)FDA Link 03/2006 - 12/2002
2	Protein AggregatesIBA 01/2021 - 01/2012
2	tau Proteins (tau Protein)IBA 10/2020 - 08/2011
2	Messenger RNA (mRNA)IBA 01/2017 - 02/2005
2	Natalizumab (Tysabri)FDA Link 03/2016 - 10/2013
2	Growth Hormone (Somatotropin)IBA 01/2016 - 05/2012
2	Endopeptidase K (Proteinase K)IBA 11/2013 - 03/2009
2	Monoclonal AntibodiesIBA 10/2013 - 01/2002
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2008 - 03/2006
2	AntigensIBA 06/2008 - 07/2004
2	SurvivinIBA 10/2005 - 05/2005
2	Amyloid beta-PeptidesIBA 09/2005 - 04/2002
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2005 - 04/2003
2	Mitochondrial DNA (mtDNA)IBA 01/2005 - 03/2003
2	trioctyl phosphine oxide (TOPO)IBA 07/2004 - 03/2002
2	Complement System Proteins (Complement)IBA 02/2004 - 09/2003
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2002 - 03/2002
1	SphingolipidsIBA 10/2020
1	Histones (Histone)IBA 01/2018
1	lipopigmentsIBA 08/2017
1	CystatinsIBA 01/2017
1	Apolipoprotein E4IBA 01/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2014
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2014

Therapy/Procedure

3	Therapeutics 09/2016 - 04/2002
2	Drug Therapy (Chemotherapy) 07/2002 - 03/2002
1	Transplantation 01/2020
1	Aftercare (After-Treatment) 01/2016